Effects of different sedatives (remimazolam/propofol) on hemodynamics during gastrointestinal endoscopy in the elderly

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060474

Enrollment

Unknown

Registered

2022-06-02

Start date

2022-05-23

Completion date

Unknown

Last updated

2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

remimazolam group :remimazolam

propofol group :propofol

Eligibility

Sex/Gender

All

Age

65 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged between 65 and 99 years; 2. ASA grade I-III; 3. Body mass index (BMI) 19 -- 27 kg/m^2.

Exclusion criteria

Exclusion criteria: 1. Patients are allergic to remazolam; 2. Long-term use of painkillers; 3. Binge drinking; 4. Nervous system or schizophrenia; 5. Advanced liver or kidney disease; 6. Sleep apnea syndrome; 7. Uncontrolled hypertension with blood pressure higher than 180/120mmHg; 8. Users of psychotropic substances.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;	—

Secondary

Measure	Time frame
peripheral oxygen saturation;	—

Countries

China

Contacts

Public ContactSong Jinchao

Shidong Hospital of Shanghai

sjch2013@163.com+86 13167000520

Outcome results